PTC Therapeutics, Inc. Initiates Phase 2 Clinical Trial of ataluren (PTC124(R)) in Patients with Hemophilia
10/26/2009 8:29:23 AM
More...
|
PTC Therapeutics, Inc. Initiates Registration-Directed Phase 3 Trial of Ataluren in Cystic Fibrosis
9/10/2009 8:34:16 AM
More...
|
PTC Therapeutics, Inc. Announces Celgene (CELG) Exercised Option to Drug Discovery Collaboration
9/2/2009 11:37:40 AM
More...
|
PTC Therapeutics, Inc. Announces Drug Discovery Collaboration With Roche (RHHBY) (JOBS); PTC May Earn up to $239 Million
9/2/2009 6:41:07 AM
More...
|
PTC Therapeutics, Inc. Announces Achievement of Major Milestone in Schering Corporation (JOBS) Hepatitis C Collaboration; PTC Received $2 Million Payment
8/10/2009 6:38:20 AM
More...
|
PTC Therapeutics, Inc. Initiates Phase 2 Clinical Trial of PTC299 in Patients with Neurofibromatosis Type 2
7/27/2009 8:38:50 AM
More...
|
PTC Therapeutics, Inc. Receives $2.6 Million in Government Grants
6/15/2009 9:18:08 AM
More...
|
PTC Therapeutics, Inc. Appoints Clare Kennedy as Vice President of Commercial Operations
6/1/2009 12:22:15 PM
More...
|
PTC Therapeutics, Inc. and Spinal Muscular Atrophy Foundation Announce $8.5 Million Small Molecule Development Collaboration
5/12/2009 7:26:59 AM
More...
|
PTC Therapeutics, Inc. Completes Enrollment of Pivotal Trial in Muscular Dystrophy
2/3/2009 10:43:52 AM
More...
|
|